BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27706405)

  • 1. Strengthening of regulatory systems for medicines in the Americas.
    Etienne C; Califf R
    Rev Panam Salud Publica; 2016 May; 39(5):213-214. PubMed ID: 27706405
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving safety, quality and efficacy of medicines in the Americas.
    Bolaños R; Bond K; Child R; Coto JV; Cummings R; Dellepiane N; Fitzgerald J; Parker C; Pereira P; Sánchez Y Tépoz J; Stergachis A
    Rev Panam Salud Publica; 2016 May; 39(5):215-216. PubMed ID: 27706408
    [No Abstract]   [Full Text] [Related]  

  • 3. Fifty years of the European medicines regulatory network: reflections for strengthening intra-regional cooperation in the Region of the Americas.
    Allchurch MH; Barbano DB; Pinheiro MH; Lazdin-Helds J
    Rev Panam Salud Publica; 2016 May; 39(5):288-293. PubMed ID: 27706411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Strengthening health regulation in the Americas: regulatory authorities of regional reference].
    Ojeda LP; Cristiá RP
    Rev Panam Salud Publica; 2016 May; 39(5):294-298. PubMed ID: 27706406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sharing regulatory data as tools for strengthening health systems in the Region of the Americas.
    Sousa VD; Ramalho PI; Silveira D
    Rev Panam Salud Publica; 2016 May; 39(5):245-254. PubMed ID: 27706398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotechnological products in Pan American Health Organization (PAHO): regional efforts towards harmonization of regulation.
    Pombo ML
    Biologicals; 2011 Sep; 39(5):348. PubMed ID: 21873078
    [No Abstract]   [Full Text] [Related]  

  • 7. [Strengthening the Pan American Network of Official Medicines Control Laboratories].
    Parisi JM; Cairatti D; Castro JL
    Rev Panam Salud Publica; 2016 May; 39(5):255-261. PubMed ID: 27706410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterfeit drugs: an Australian perspective.
    Hensey CC; Gwee A
    Med J Aust; 2016 May; 204(9):344. PubMed ID: 27169964
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of similar biotherapeutic products: scientific and regulatory challenges.
    Griffiths E; Thorpe R; Wadhwa M; Sohn Y
    Biologicals; 2011 Sep; 39(5):249. PubMed ID: 21925898
    [No Abstract]   [Full Text] [Related]  

  • 10. Counterfeit anti-infective drugs.
    Newton PN; Green MD; Fernández FM; Day NP; White NJ
    Lancet Infect Dis; 2006 Sep; 6(9):602-13. PubMed ID: 16931411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [European legislation on biological similarity recommendations of the European Agency on Medications concerning drug quality].
    Prugnaud JL
    Nephrol Ther; 2009 Feb; 5 Spec No1():3-5. PubMed ID: 19233075
    [No Abstract]   [Full Text] [Related]  

  • 12. Medicines pricing singled out.
    Buchanan E
    S Afr Med J; 2004 May; 94(5):334. PubMed ID: 15211941
    [No Abstract]   [Full Text] [Related]  

  • 13. A new public health journal for the Americas.
    Alleyne G
    Rev Panam Salud Publica; 1997 Jan; 1(1):1-2. PubMed ID: 9128107
    [No Abstract]   [Full Text] [Related]  

  • 14. China's perspective on similar biotherapeutic products.
    Liang C; Wang J
    Biologicals; 2011 Sep; 39(5):312-6. PubMed ID: 21924622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Policy in the Real World.
    Pullen LC
    Am J Transplant; 2019 Nov; 19(11):2963-2964. PubMed ID: 31742915
    [No Abstract]   [Full Text] [Related]  

  • 16. An Indian manufacturer's perspective for harmonization of guidelines for similar biotherapeutic products.
    Babu PV
    Biologicals; 2011 Sep; 39(5):300-3. PubMed ID: 21816621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting public health and protecting consumers in a global economy: an overview of HHS/FDA's international activities.
    Kelly DP; Bachorik LL
    Food Drug Law J; 2005; 60(3):339-46. PubMed ID: 16304741
    [No Abstract]   [Full Text] [Related]  

  • 19. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Supplements: Foods, Medicines, or Both? A Controversial Designation with Unspecific Legislation.
    Pereira C; Barros L; Ferreira ICFR
    Curr Pharm Des; 2017; 23(19):2722-2730. PubMed ID: 28124610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.